[en] Tumour-derived extracellular vesicles (EVs) participate in tumour progression by deregulating various physiological processes including angiogenesis and inflammation. Here we report that EVs released by endothelial cells in a mammary tumour environment participate in the recruitment of macrophages within the tumour, leading to an immunomodulatory phenotype permissive for tumour growth. Using RNA-Seq approaches, we identified several microRNAs (miRNAs) found in endothelial EVs sharing common targets involved in the regulation of the immune system. To further study the impact of these miRNAs in a mouse tumour model, we focused on three miRNAs that are conserved between humans and mouse, that is, miR-142-5p, miR-183-5p and miR-222-3p. These miRNAs are released from endothelial cells in a tumour microenvironment and are transferred via EVs to macrophages. In mouse mammary tumour models, treatment with EVs enriched in these miRNAs leads to a polarization of macrophages toward an M2-like phenotype, which in turn promotes tumour growth.
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE] ULiège - Université de Liège [BE] Fonds Léon Fredericq [BE]
Funding number :
PDR T 1096.14
Funding text :
This study was supported by the University of Liège (ARC: RNAngio), the FNRS (Fonds National de la Recherche Scientifique, Belgium) (PDR T 1096.14), and the Léon Frédéricq fund. Computational resources have been provided by the Consortium des Équipements de Calcul Intensif (CÉCI), funded by the Fonds de la Recherche Scientifique de Belgique (F.R.S.-FNRS) under Grant No. 2.5020.11 and by the Walloon Region.
Agarwal, V., Bell, G. W., Nam, J. - W., & Bartel, D. P. (2015). Predicting effective microRNA target sites in mammalian mRNAs. Elife, 4, e05005.
Arwert, E N., Harney, A S., Entenberg, D., Wang, Y., Sahai, E., Pollard, J. W., & Condeelis, J S. (2018). A unidirectional transition from migratory to perivascular macrophage is required for tumor cell intravasation. Cell Reports, 23, 1239–1248.
Azizi, E., Carr, A J., Plitas, G., Cornish, A E., Konopacki, C., Prabhakaran, S., Nainys, J., Wu, K., Kiseliovas, V., Setty, M., Choi, K., Fromme, R M., Dao, P., Mckenney, P T., Wasti, R C., Kadaveru, K., Mazutis, L., Rudensky, A Y., & Pe'er, D. (2018). Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell, 174, 1293–1308.
Betancur, J G., Yoda, M., & Tomari, Y. (2012). miRNA-like duplexes as RNAi triggers with improved specificity. Fronties in Genetics, 3, 2008–2013.
Bovy, N., Blomme, B., Frères, P., Dederen, S., Nivelles, O., Lion, M., Carnet, O., Martial, J A., Noël, A., Thiry, M., Jérusalem, G., Josse, C., Bours, V., Tabruyn, S P., & Struman, I. (2015). Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget, 6, 10253–10266.
Cassetta, L., Fragkogianni, S., Sims, A H., Swierczak, A., Forrester, L M., Zhang, H., Soong, D. Y. H., Cotechini, T., Anur, P., Lin, E Y., Fidanza, A., Lopez-Yrigoyen, M., Millar, M R., Urman, A., Ai, Z., Spellman, P T., Hwang, E. S, Dixon, J. M, Wiechmann, L., … Pollard, J. W. (2019). Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets. Cancer Cell, 35, 588–602.e10.
Cassetta, L., & Pollard, J. W. (2018). Targeting macrophages: Therapeutic approaches in cancer. Nature Reviews Drug Discovery, 17, 887–904.
Chevillet, J R., Kang, Q., Ruf, I K., Briggs, H A., Vojtech, L N., Hughes, S M., Cheng, H H., Arroyo, J D., Meredith, E K., Gallichotte, E N., Pogosova-Agadjanyan, E L., Morrissey, C., Stirewalt, D L., Hladik, F., Yu, E Y., Higano, C S., & Tewari, M. (2014). Quantitative and stoichiometric analysis of the microRNA content of exosomes. PNAS, 111, 14888–14893.
Colombo, M., Raposo, G., & Théry, C. (2014). Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annual Review of Cell and Developmental Biology, 30, 255–289.
Cooks, T., Pateras, I S., Jenkins, L M., Patel, K M., Robles, A I., Morris, J., Forshew, T., Appella, E., Gorgoulis, V G., & Harris, C C. (2018). Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. Nature Communication, 9(1), 771.
He, S., Wu, C., Xiao, J., Li, D., Sun, Z., & Li, M. (2018). Endothelial extracellular vesicles modulate the macrophage phenotype: Potential implications in atherosclerosis. Scandinavian Journal of Immunology, 87(4), e12648.
Kozomara, A., Birgaoanu, M., & Griffiths-Jones, S. (2019). MiRBase: From microRNA sequences to function. Nucleic Acids Research, 47, D155–D162.
Li, B., Lu, Y., Wang, H., Han, X., Mao, J., Li, J., Yu, L., Wang, B., Fan, S., Yu, X., & Song, B. (2016). miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway. Biomedicine & Pharmacotherapy, 79, 93–101.
Li, N., Qin, J., Lan, L., Zhang, H., Liu, F., Wu, Z., Ni, H., & Wang, Y. (2015). PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism. Cancer Biology & Therapy, 16, 297–306.
Li, S., Li, Q., Lü, J., Zhao, Q., Li, D., Shen, L., Wang, Z., Liu, J., Xie, D., Cho, W C., Xu, S., & Yu, Z. (2020). Targeted inhibition of miR-221/222 promotes cell sensitivity to cisplatin in triple-negative breast cancer MDA-MB-231 CELlS. Frontiers in Genetics, 10, 1278.
Liang, X., Zhang, L., Wang, S., Han, Q., & Zhao, R. C. (2016). Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. Journal of Cell Science, 129, 2182–2189.
Lennox, K A., & Behlke, M A. (2010). A direct comparison of anti-microRNA oligonucleotide potency. Pharmaceutical Research, 27, 1788–1799.
Ludwig, N., & Whiteside, T L. (2018). Potential roles of tumor-derived exosomes in angiogenesis. Expert Opinion on Therapeutic Targets, 22, 409–417. https://doi.org/10.1080/14728222.2018.1464141 [PREPRINT]
Martinez, F O., Gordon, S., Locati, M., & Mantovani, A. (2006). Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. Journal of Immunology, 177, 7303–7311.
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van Den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., & Van Ginderachter, Jo A. (2010). Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Research, 70, 5728–5739.
Njock, M. S., Cheng, H S., Dang, L T., Nazari-Jahantigh, M., Lau, A C., Boudreau, E., Roufaiel, M., Cybulsky, M I., Schober, A., & Fish, J E. (2015). Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs. Blood, 125, 3202–3212.
Orecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2019). Macrophage polarization: Different gene signatures in M1(Lps+) vs. Classically and M2(LPS-) vs. alternatively activated macrophages. Frontiers in Immunology, 10, 1–14.
Ozawa, P M. M., Vieira, E., Lemos, D S., Souza, I L. M, Zanata, S M., Pankievicz, V C., Tuleski, T R., Souza, E. M., Wowk, P. F., Urban, C. D. A, Kuroda, F., Lima, R S., Almeida, R. C., Gradia, D F., Cavalli, I. J., Cavalli, L R., Malheiros, D., & Ribeiro, E M. S. F. (2020). Identification of miRNAs enriched in extracellular vesicles derived from serum samples of breast cancer patients. Biomolecules, 150, 10.
Park, J. E., Dutta, B., Tse, S. W., Gupta, N., Tan, C. F., Low, J. K., Yeoh, K. W., Kon, O. L., Tam, J P., & Sze, S. K. (2019). Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift. Oncogene, 38, 5158–5173.
Qian, J., Olbrecht, S., Boeckx, B., Vos, H., Laoui, D., Etlioglu, E., Wauters, E., Pomella, V., Verbandt, S., Busschaert, P., Bassez, A., Franken, A., Bempt, M. V., Xiong, J., Weynand, B., Van Herck, Y., Antoranz, A., Bosisio, F. M., Thienpont, B., … Lambrechts, D. (2020). A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Research, 30, 745–762.
Rodríguez-Martínez, A., De Miguel-Pérez, D., Ortega, F. G., García-Puche, J. L., Robles-Fernández, I., Exposito, J., Martorell-Marugan, J., Carmona-Sáez, P., Garrido-Navas, M. D. C., Rolfo, C., Ilyine, H., Lorente, J. A., Legueren, M., & Serrano, M. J. (2019). Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy. Breast Cancer Research, 21(1), 21.
Van Solingen, C., Seghers, L., Bijkerk, R., Duijs, J. M. G. J., Roeten, M. K., Van Oeveren-Rietdijk, A. M., Baelde, H. J., Monge, M., Vos, J. B., De Boer, H. C., Quax, P. H. A., Rabelink, T. J., & Jan Van Zonneveld, A. (2009). Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. Journal of Cellular and Molecular Medicine, 13, 1577–1585.
Song, Q., An, Q., Niu, B., Lu, X., Zhang, N., & Cao, X. (2019). Role of miR-221/222 in tumor development and the underlying mechanism. Journal of Oncology, 2019, 1–15.
Song, Q., Hawkins, G A., Wudel, L., Chou, P. -. C., Forbes, E., Pullikuth, A K., Liu, L., Jin, G., Craddock, L., Topaloglu, U., Kucera, G., O'neill, S., Levine, E A., Sun, P., Watabe, K., Lu, Y., Alexander-Miller, M A., Pasche, B., Miller, L D., & Zhang, W. (2019). Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq. Cancer Medicine, 8, 3072–3085.
Stinson, S., Lackner, M. R., Adai, A. T., Yu, N., Kim, H. J., O'brien, C., Spoerke, J., Jhunjhunwala, S., Boyd, Z., Januario, T., Newman, R. J., Yue, P., Bourgon, R., Modrusan, Z., Stern, H. M., Warming, S., De Sauvage, F. J., Amler, L., Yeh, R. - F., & Dornan, D. (2011). TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Science Signaling, 4, ra41–ra41.
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin-Smith, G. K., Craig Ayre, D., Jean-Marie, B., Bachurski, D., Baharvand, H., Balaj, H., Baldacchino, S., Bauer, N. N., Baxter, A. A., Bebawy, M., … Zuba-Surma, E. K. (2019). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles, 8, 1535750.
Tuit, S., Salvagno, C., Kapellos, T. S., Hau, C. S., Seep, L., Oestreich, M., Klee, K., De Visser, K. E., Ulas, T., & Schultze, J. L. (2019). Transcriptional signature derived from murine tumor-associated macrophages correlates with poor outcome in breast cancer patients. Cell Reports, 29, 1221–1235.
Wang, H., Ma, Z., Liu, X., Zhang, C., Hu, Y., Ding, L., Qi, P., Wang, J., Lu, S., & Li, Y. (2019). MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN. Biomedicine & Pharmacotherapy, 111, 1103–1111.
Wang, X., Luo, G., Zhang, K., Cao, J., Huang, C., Jiang, T., Liu, B., Su, L., & Qiu, Z. (2018). Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kg to promote pancreatic cancer metastasis. Cancer Research, 78, 4586–4598.
Wortzel, I., Dror, S., Kenific, C M., & Lyden, D. (2019). Exosome-mediated metastasis: communication from a distance. Developmental Cell, 49, 347–360.
Xu, W., & Wang, W. (2018). MicroRNA-142-5p modulates breast cancer cell proliferation and apoptosis by targeting phosphatase and tensin homolog. Molecular Medicine Reports, 17, 7529–7536.
Zhou, C., Zhang, Y., Yan, R., Huang, L., Mellor, A. L., Yang, Y., Chen, X., Wei, W., Wu, X., Yu, L., Liang, L., Zhang, D., Wu, S., & Wang, W. (2021). Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment. Cell Death and Differentiation, 28, 715–729.
